original articlesthoracic tumorsMaintenance bevacizumab–pemetrexed after first-line cisplatin–pemetrexed–bevacizumab for advanced nonsquamous nonsmall-cell lung cancer: updated survival analysis of the AVAPERL (MO22089) randomized phase III trial
thoracic tumors
Under an Elsevier user license
open archive
Keywords
nonsquamous
nonsmall-cell lung cancer
bevacizumab
pemetrexed
maintenance
chemotherapy
Cited by (0)
Copyright © 2014 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved.